|
|
|
Insider
Information: |
Lowenthal Richard E |
Relationship: |
|
City: |
San Diego |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
4,315,313 |
|
Indirect Shares
|
6,844,793 |
|
|
Direct
Value |
$0 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
11,160,106 |
|
|
Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Cadence Pharmaceuticals Inc |
CADX |
Officer |
|
0 |
2006-10-24 |
141,000 |
Premium* |
|
Silverback Therapeutics, Inc. |
SBTX |
|
2024-06-12 |
4,315,313 |
2024-06-12 |
6,703,793 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
26 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 2
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
SBTX |
Silverback Therapeutics, ... |
President and CEO |
|
2022-11-08 |
4 |
A |
$0.00 |
$0 |
D/D |
5,176,822 |
5,176,822 |
0 |
- |
|
SBTX |
Silverback Therapeutics, ... |
President and CEO |
|
2022-11-08 |
4 |
A |
$0.00 |
$0 |
I/I |
7,872,554 |
1,772,850 |
0 |
- |
|
SBTX |
Silverback Therapeutics, ... |
President and CEO |
|
2023-05-17 |
4 |
GA |
$0.00 |
$0 |
I/I |
2,100,000 |
2,100,000 |
0 |
- |
|
SBTX |
Silverback Therapeutics, ... |
President and CEO |
|
2023-05-17 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,050,000 |
4,126,822 |
0 |
- |
|
SBTX |
Silverback Therapeutics, ... |
President and CEO |
|
2023-05-17 |
4 |
GD |
$0.00 |
$0 |
I/I |
1,050,000 |
3,276,854 |
0 |
- |
|
SBTX |
Silverback Therapeutics, ... |
PRESIDENT AND CEO |
|
2024-02-26 |
4 |
AS |
$9.01 |
$6,307 |
I/I |
(700) |
1,772,750 |
0 |
- |
|
SBTX |
Silverback Therapeutics, ... |
PRESIDENT AND CEO |
|
2024-02-28 |
4 |
AS |
$9.02 |
$891,061 |
I/I |
(98,778) |
1,748,447 |
0 |
- |
|
SBTX |
Silverback Therapeutics, ... |
PRESIDENT AND CEO |
|
2024-02-29 |
4 |
AS |
$9.01 |
$34,101 |
I/I |
(3,782) |
1,747,447 |
0 |
- |
|
SBTX |
Silverback Therapeutics, ... |
PRESIDENT AND CEO |
|
2024-03-13 |
4 |
AS |
$9.00 |
$25,200 |
I/I |
(2,800) |
2,047,199 |
0 |
- |
|
SBTX |
Silverback Therapeutics, ... |
PRESIDENT AND CEO |
|
2024-03-14 |
4 |
AS |
$9.00 |
$3,996 |
I/I |
(444) |
2,046,960 |
0 |
- |
|
SBTX |
Silverback Therapeutics, ... |
PRESIDENT AND CEO |
|
2024-03-15 |
4 |
AS |
$9.14 |
$884,485 |
I/I |
(96,756) |
1,998,499 |
0 |
- |
|
SBTX |
Silverback Therapeutics, ... |
PRESIDENT AND CEO |
|
2024-03-19 |
4 |
AS |
$9.03 |
$17,324 |
I/I |
(1,918) |
1,997,557 |
0 |
- |
|
SBTX |
Silverback Therapeutics, ... |
PRESIDENT AND CEO |
|
2024-03-21 |
4 |
AS |
$9.00 |
$4,248 |
I/I |
(472) |
1,997,457 |
0 |
- |
|
SBTX |
Silverback Therapeutics, ... |
PRESIDENT AND CEO |
|
2024-03-22 |
4 |
AS |
$9.01 |
$21,135 |
I/I |
(2,343) |
1,996,131 |
0 |
- |
|
SBTX |
Silverback Therapeutics, ... |
PRESIDENT AND CEO |
|
2024-03-25 |
4 |
AS |
$9.12 |
$869,188 |
I/I |
(95,267) |
1,948,499 |
0 |
- |
|
SBTX |
Silverback Therapeutics, ... |
PRESIDENT AND CEO |
|
2024-04-09 |
4 |
AS |
$9.28 |
$927,735 |
I/I |
(100,000) |
1,898,499 |
0 |
- |
|
SBTX |
Silverback Therapeutics, ... |
PRESIDENT AND CEO |
|
2024-04-16 |
4 |
AS |
$9.28 |
$928,005 |
I/I |
(100,000) |
1,848,499 |
0 |
- |
|
SBTX |
Silverback Therapeutics, ... |
PRESIDENT AND CEO |
|
2024-04-19 |
4 |
OE |
$0.84 |
$199,999 |
D/D |
188,491 |
4,315,313 |
0 |
- |
|
SBTX |
Silverback Therapeutics, ... |
PRESIDENT AND CEO |
|
2024-04-23 |
4 |
OE |
$0.84 |
$138,990 |
I/I |
130,993 |
3,407,847 |
0 |
- |
|
SBTX |
Silverback Therapeutics, ... |
PRESIDENT AND CEO |
|
2024-05-07 |
4 |
AS |
$9.34 |
$934,365 |
I/I |
(100,000) |
1,798,499 |
0 |
- |
|
SBTX |
Silverback Therapeutics, ... |
PRESIDENT AND CEO |
|
2024-05-14 |
4 |
AS |
$9.01 |
$51,854 |
I/I |
(5,757) |
1,795,615 |
0 |
- |
|
SBTX |
Silverback Therapeutics, ... |
PRESIDENT AND CEO |
|
2024-05-15 |
4 |
AS |
$9.04 |
$46,565 |
I/I |
(5,147) |
1,792,849 |
0 |
- |
|
SBTX |
Silverback Therapeutics, ... |
PRESIDENT AND CEO |
|
2024-05-16 |
4 |
AS |
$9.06 |
$807,023 |
I/I |
(89,096) |
1,748,499 |
0 |
- |
|
SBTX |
Silverback Therapeutics, ... |
PRESIDENT AND CEO |
|
2024-06-11 |
4 |
AS |
$9.00 |
$37,254 |
I/I |
(4,138) |
1,746,527 |
0 |
- |
|
SBTX |
Silverback Therapeutics, ... |
PRESIDENT AND CEO |
|
2024-06-12 |
4 |
AS |
$9.14 |
$876,663 |
I/I |
(95,862) |
1,698,499 |
0 |
- |
|
26 Records found
|
|
Page 1 of 2 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|